KLF3-AS1: A Potential Drug Target and Biomarker (G79667)

Target Name: KLF3-AS1

NCBI ID: G79667

Other Name(s): KLF3 antisense RNA 1 | KLF3-AS1 variant 1

KLF3-AS1: A Potential Drug Target and Biomarker

KLF3-AS1, also known as KLF3 antisense RNA 1, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its unique structure and function make it an intriguing candidate for further research.

The KLF3 gene is located on chromosome 6p12 and encodes for the KLF3 protein, which is a non-coding RNA-binding protein that plays a role in regulating gene expression. The KLF3 gene has been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

KLF3-AS1 is a non-coding RNA molecule that is derived from the KLF3 gene. It is characterized by a unique structure that consists of a single exon that is spliced from the 5' end of the KLF3 gene. The exon is surrounded by a series of intron retention sites, which prevent the exon from being removed during splicing.

The function of KLF3-AS1 is not well understood, but its unique structure and location on chromosome 6p12 suggest that it plays an important role in the regulation of gene expression. Studies have shown that KLF3-AS1 is highly expressed in various tissues and organs, including brain, heart, liver, and pancreas. It is also expressed in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

As a potential drug target, KLF3-AS1 is of interest due to its unique structure and function. Its expression is highly correlated with the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. It is also expressed in diseases that are associated with increased risk of adverse side effects, such as neurodegenerative diseases and cancer.

Furthermore, its unique structure and function make it an attractive biomarker for diagnostic and therapeutic applications. Its expression is highly correlated with the progression of various diseases, making it a potential target for diagnostic tests. Its expression is also correlated with the response to therapeutic treatments, making it a potential target for therapeutic applications.

In conclusion, KLF3-AS1 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its unique structure and function make it an intriguing candidate for further research. Further studies are needed to determine its function and its potential as a drug target and biomarker.

Protein Name: KLF3 Antisense RNA 1

More Common Targets